SignPath Pharma (www.signpathpharma.com) is a clinical stage biotechnology company (Delaware C Corp.) founded in 2006. Currently, SignPath is actively developing products to treat cancer and mitigate drug-induced cardiac arrhythmia, which is a serious and common side effect of many drugs, and heart muscle damage caused by chemotherapy.
Company Details
- Employees
- 11
- Founded
- -
- Address
- 9710 Ruskin Cir, Sandy,utah 84092,united States
- Phone
- 3153833496
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://signpathpharma.com
- Keywords
- Pharmaceuticals.
- HQ
- Sandy, Utah
Signpath Pharma Inc. Questions
Signpath Pharma Inc.'s helpline number is 3153833496
Signpath Pharma Inc.'s website is http://signpathpharma.com
Signpath Pharma Inc.'s LinkedIn profile is https://www.linkedin.com/company/signpath-pharma-inc-
Signpath Pharma Inc. has
11 employees.
View email and phone details for 11
employees at Signpath Pharma Inc..
Signpath Pharma Inc.'s industry is
Pharmaceutical Manufacturing
Signpath Pharma Inc.'s top competitors are
Juneau Biosciences,
Carterra,
Synovel Laboratory, Llc,
Biolexis Therapeutics, Inc.,
Simcha Therapeutics,
Sorriso Pharmaceuticals,
Echelon Biosciences,
Teiko,
3helix, Inc.,
Thunder Biotech.
Signpath Pharma Inc.'s categories are Pharmaceutical Manufacturing
Signpath Pharma Inc.'s founding year is 2006
